This activity is supported by an educational grant from Genentech, Inc.
The management of patients with hematologic malignancies—from diagnosis to treatment decisions—can represent a… More »
This activity is supported by educational grants from Genentech, Inc. and Merck & Co., Inc.
Globally, lung cancer is the leading cause of cancer-related deaths. Eighty-five percent of lung cancers are non-small… More »